MCM
IRMD icon

McKinley Capital Management’s iRadimed IRMD Stock Holding History

McKinley Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-89,598
Closed -$1.52M – 533
2016
Q3 		$1.52M Buy
89,598
+16
+0% +$296 0.05% 215
2016
Q2 		$1.95M Sell
89,582
-25
-0% -$450 0.09% 193
2016
Q1 		$1.72M Buy
+89,607
New +$1.71M 0.08% 194

Other funds holding IRMD

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

McKinley Capital Management's IRMD Position: Q4 2016 in Review

McKinley Capital Management sold out of iRadimed (IRMD) in Q4 2016, closing a stake of 89,598 shares — an estimated $1.52M sold.

McKinley Capital Management first reported a position in IRMD in Q1 2016 and held it in 3 quarters. The position peaked at $1.95M in Q2 2016. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

  • McKinley Capital Management reported no remaining iRadimed position as of Q4 2016 after selling out during the quarter.
  • McKinley Capital Management sold 89,598 iRadimed shares in Q4 2016, an estimated $1.52M.
  • McKinley Capital Management first reported a position in iRadimed in Q1 2016 and held it in 3 quarters.
  • McKinley Capital Management's iRadimed position peaked at $1.95M in Q2 2016.
  • 58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on McKinley Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.